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General Introduction 
This thesis is formed by the amalgamation of three scientific papers (unpublished) covering 
differing subjects within the fields of comparative and veterinary medicine.  The specific aims 
of each project, listed below, were diverse.  Each was designed to involve a brief literature 
review with hypothesis formulation, an investigative phase, and finally the production of a 
document for inclusion in this thesis.  Projects 1 and 3 were practical, ‘wet-lab’ investigations 
into aspects of human and animal disease in the developing world, whereas project 2 involved 
analysis of existing data.  All three projects contributed to the bank of knowledge on human 
and animal disease, and contained elements concerning infectious disease research.  Over the 
past  decades  a  greater  awareness  for  the  need  to  combine  research  from  medical  and 
veterinary spheres has arisen, due to the geographical and  genetic impermanence, and the 
connectedness of these populations.  With this principle in mind, the projects included in this 
thesis  feature  elements  of  epidemiology,  laboratory-based  investigative  methods  and  data 
analysis which are relevant to the study of disease in both the human and animal medical 
fields. 
 
The specific research questions posed were as follows: 
 
Project 1 
·  Can a known cathepsin L-like inhibitor (K11777) affect the generation of spontaneous 
Ca
2+  ‘waves’  in  isolated adult  rat  cardiomyocytes  exposed  to  the  supernatant  from 
suspensions of Trypanosoma brucei brucei, suggesting that this parasite produces a 
cathepsin L-like protease which affects cardiovascular tissues? 
·  Does the use of the protease-activated receptor (PAR) activating-peptide SLIGRL-NH2 
alter the production of spontaneous Ca
2+ ‘waves’ in isolated adult rat cardiomyocytes, 
suggesting a role for PAR 2 in ‘wave’ production? 
 
 
 
 
 
   C. E. Walls    0910764w 
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Project 2 
·  Did  the  profile  of  reported  disease  in  the  equine  population  of  northern  UK  alter 
between  the  1960s  and  the  1990s?    Can  hypotheses  be  developed  about  why  any 
changes may have occurred? 
 
Project 3 
·  What  is  the  prevalence  of  Giardia  and  Cryptosporidium  in  a  small  subset  of  the 
domestic animal faecal samples submitted to the Kenyan Medical Research Institute 
(KEMRI)  as  part  of  the  ‘Global  Enterics  Multi-Centre  Study  Zoonotic  Enteric 
Diseases’ (GEMS-ZED) project? 
·  Using  a  small  subset  of  the  existing  data  in  the  GEMS-ZED  project,  what  is  the 
prevalence of the major zoonotic enteric pathogens in diarrhoeic and non-diarrhoeic 
children and the domestic animals in their vicinity, in an area of rural western Kenya? 
·  Can these figures be used to generate strategies to reduce the morbidity and mortality 
of young children from diarrhoea in future? 
   C. E. Walls    0910764w 
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CHAPTER 1 - Trypanosomiasis and the Heart: Evaluation of the 
effects African Trypanosomiasis on isolated adult rat 
cardiomyocytes  
 
Abstract 
Human  African  Trypanosomiasis  causes  cardiac  rhythm  disturbances  through 
hitherto unknown mechanisms.  It is known that the presence of such protozoan 
parasites  or  simply  their  supernatant  has  excitatory  effects  on  isolated 
cardiomyocytes, seen as increased Ca
2+ wave occurrence.   We investigated the 
theory that the protozoa are able to release a cathepsin L-like product into solution 
which is the initiator of such waves.  Adult rat left ventricular cardiomyocytes 
were isolated in solution before [Ca
2+] was raised to physiological extracellular 
concentration.    The  cells  were  then  exposed  to  pH  controlled  samples  of 
supernatant,  with  or  without  a  known  cathepsin  L-like  protease  inhibitor 
(K11777), and all were subjected to population studies of wave incidence over 60 
second timeframes.   
Results 
Baseline percentage of spontaneously waving cells in mock extracellular solution 
was  found  to  be  significantly  lower  than  with  the  presence  of  Trypanosome 
supernatant.   Addition  of  K11777  led  to  a  significant  reduction in  spontaneity 
toward baseline.  These results suggest that T. b. brucei produces a cathepsin L-
like cysteine protease which causes increased incidence of Ca
2+ waves. 
 
1.1   Introduction 
 
Protozoan parasites of the genus Trypanosoma are responsible for a great deal of morbidity 
and mortality in both humans and veterinary species in many parts of the world.  In particular, 
sub-Saharan Africa suffers heavily from the economic and welfare impacts of the causative 
agents  of  Human  African  Trypanosomiasis  (HAT),  T.  brucei  rhodesiense  and  T.  brucei 
gambiense  (East,  and  West  African  Trypanosomiasis,  respectively).    The vast  majority  of 
HAT cases are of the West African form (Blum et al. 2006).  HAT is spread by bites from C. E. Walls    0910764w 
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infected Tsetse flies (Glossina spp.) and occurs in two clinical stages.  In the first, or ‘haemo-
lymphatic’ stage, patients typically suffer lymphadenopathy, intermittent fever, pruritis and 
arthralgia (Blum et al. 2006).  Upon penetration of the parasite beyond the blood-brain barrier 
(BBB),  the  second  ‘meningo-encephalitic’  stage  commences.    Symptoms  include  night 
insomnia,  daytime  somnolence  (from  which  the  disease  acquires  the  name  ‘Sleeping 
Sickness’),  headaches,  disturbed  behaviour,  epiletiform  attacks  and  other  markers  of 
neurological and  psychological  derangement  (Blum  et  al.  2006).    Without  treatment  most 
victims succumb to the disease over a period of months to years.  It is thought that at present, 
17,500 new cases of HAT are diagnosed yearly, with a prevalence of 50,000 to 70,000 in the 
36 countries at risk (www.who.int 2010).  Difficulties in obtaining epidemiological data from 
less  developed  but  geographically  expansive  parts  of  the  continent  mean  that  the  current 
incidence  and  prevalence  data  are  likely  to  be  underestimates.    Current  treatments  are 
inadequate due to high levels of toxicity, their failure to rid the patient of all parasites despite 
prolonged treatment regimens, and the emergence of parasite resistance. 
 
Cardiac  arrhythmias  are  reported  in  up  to  71%  of  cases  of  HAT,  but  are  thought  not  to 
contribute  significantly  to  mortality  (Blum  et  al.  2008).    Electrocardiographic  alterations 
observed include prolonged  QTc intervals, repolarisation changes and low voltages, all of 
which  are  consistent  with  peri-myocarditis  and  can  be  seen  early  in  disease  progression. 
Studies have shown that up to 72% of patients have histological changes to the heart found at 
post-mortem (Blum et al. 2008).   
 
It has long been known that alterations in Ca
2+ handling in heart cells can lead to spontaneous 
contractile events known as ‘Ca
2+ waves’ in individual cells, which are implicated in various 
arrhythmias  (Cheng  and  Lederer 2008).    Recently,  it  was  discovered  that  the  presence  of 
Trypanosoma  species  could  elicit  a  high  frequency  of  such  waves  when  introduced  to 
suspensions of isolated adult dog cardiomyocytes (Barr et al. 1996).  Interestingly, the same 
effect  is  noted  on  addition  of  only  the  supernatant  from  cultured  parasites,  without  the 
presence  of  protozoa  (Barr  et  al.  1996).    It  was  hypothesized  that  the  high  degree  of 
spontaneous  activity  seen  was  due  to  the  binding  of  some  unknown  excretory/secretory 
product  produced  by  the  Trypanosomes,  to  cardiomyocyte  receptors,  leading  to  an 
intracellular  signalling  cascade  resulting  in  a  wave.    This  product  was  thought  to  be  a 
cathepsin L-like cysteine protease (Barr et al. 1996; Grab et al. 2009). C. E. Walls    0910764w 
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1.1.1 Physiological Excitation-Contraction Coupling 
 
Intracellular Ca
2+ control is central to the regulation of contraction and relaxation of individual 
cardiomyocytes, and therefore also the synchronization of heart chamber contraction.  At rest, 
the cytoplasmic Ca
2+  concentration  is  maintained at much  lower  concentrations  (100  nM) 
compared  with  the  extracellular  domain  (Bers  and  Guo  2005).    This  is  achieved  by  the 
sequestration of Ca
2+ within the sarcoplasmic reticulum (SR)(3 mM l
-1), an active process 
performed by the SR Ca
2+ ATPase pump (SERCA), and to a much lesser degree through slow 
Ca
2+ uptake into mitochondria, or through extrusion by sarcolemmal Ca
2+ ATPases (Bers and 
Guo 2005; Bers 2008; Cheng and Lederer 2008; Eisner 2010).  Na
+-Ca
2+ exchanger (NCX) 
pumps on the cell surface use energy generated from the flow of Na
+ down its concentration 
gradient to move Ca
2+ in the opposite direction.  This flow is reversible, depending upon 
concentrations of both Ca
2+ and Na
+, and the voltage experienced at the cell membrane (Bers 
and Guo 2005). 
 
 
Figure 1.1 Diagrammatic representation of the events occurring during an action potential.  
Diagram adapted from Donald M. Bers (Bers 2002). 
 
Upon  arrival  of  an  action  potential  (AP)  at  the  sarcolemma,  L-type  voltage-gated  Ca
2+ 
channels, located at junctional clefts within functional units known as ‘couplons’, allow a C. E. Walls    0910764w 
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surge of Ca
2+ to enter the cell, raising the intracellular Ca
2+ concentration to around 10 M 
(Bers and Guo 2005).  Within a couplon, the 25 or so L-type Ca
2+ channels are clustered close 
to up to 200 Ryanodine receptors (RyR).  These RyRs allow efflux of Ca
2+ after being induced 
by the presence of Ca
2+ itself: a process known as Ca
2+-induced Ca
2+ release (CICR).  Due to 
the proximity of L-type Ca
2+ channels and RyRs the initial Ca
2+ influx triggers a much greater 
flux of Ca
2+ into the cytoplasm from the SR store.  The temporarily high voltage produced 
also  reverses  the  action  of  the  NCX  briefly  to  favour  Ca
2+  influx,  but  an  increasing 
intracellular concentration quickly halts this (Bers and Guo 2005).  A high concentration of 
Ca
2+ is then free to initiate cross-bridge cycling by binding to myofibrils.  Cessation of Ca
2+ 
influx from L-type receptors occurs due to the negative feedback afforded to the receptor from 
the presence of Ca
2+ ions at the intracellular domain (Bers and Guo 2005).  Thus the L-type 
current itself can inhibit further Ca
2+ influx, and also the SR Ca
2+ release will play a part in 
halting entry of Ca
2+ from outside the cell. The mechanism of termination of Ca
2+ release from 
the SR is not completely understood, but is thought to be dependent upon the [Ca
2+] within the 
SR (Bers 2002).  The intracellular [Ca
2+] needs then to be returned to a resting level in order 
that the cell can relax and be ready for subsequent contractions.  This is done by the SERCA 
and NCX, and to a much lesser degree by mitochondrial Ca
2+ uniporter uptake, and extrusion 
via the sarcolemmal Ca
2+ ATPase pump (Bers 2002). 
 
1.1.2 Ca
2+ Sparks and Waves 
 
In diastole, overloading of the SR with Ca
2+ such that the concentration within exceeds 100 
µM of unbound Ca
2+ is known to lead to ‘leakage’ of Ca
2+ into the cytoplasm (Cheng and 
Lederer 2008).  This Ca
2+ can then trigger CICR from local RyRs, causing a surge of ions 
which, if large enough, can cause further activation at neighbouring couplons sited about 0.7 
µm away (Barr et al. 1996; Cheng and Lederer 2008).  This cascade of non-voltage-dependent 
Ca
2+ release causes cross-bridge cycling and thus cell shortening in the same manner as APs 
during systole, and lasts around 10 ms.  Globally within the cell the movement produced is 
distinct from the effect of an AP, in that contraction occurs at a single point before spreading 
out to cover the cell.  During an AP, the entire cell contracts uniformly.  The events described 
occurring at a single couplon are termed a ‘spark’, but if a spark is able to propagate itself 
along the length of a cell it is known as a ‘wave’ (Keizer and Smith 1998; MacQuaide et al. 
2009).  Ca
2+ sparks occur in healthy cardiomyocytes at a low frequency, but rarely succeed in C. E. Walls    0910764w 
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causing ‘full blown’ waves.  A wave has consequences for the heart as a whole if it can lead to 
propagation of similar waves in neighbouring cells, thus forming a syncytium of dysregulated 
contraction which will disrupt the choreography of normal systolic events.  Waves have been 
implicated in many arrhythmias such as delayed after-depolarisations (DADs) and early after-
depolarisations (EADs) (Clusin 2003; Cheng and Lederer 2008).  EADs are depolarisations 
which commence during the plateau of  an AP, hence  are  more likely  to occur if there is 
prolongation  of  AP  duration.    They  are  mediated  through  the  L-type  cell  surface  Ca
2+ 
channels, and are clinically relevant due to their strong association with torsades des pointes 
ventricular tachycardia (Clusin 2003).  In conditions of SR Ca
2+ overload, diastolic release of 
Ca
2+ from the SR causes a reversal of directionality of the NCX ion transport such that an 
inward  current  is  temporarily  favoured.    This  inward  current  is  termed  a  DAD,  and  if 
sufficient in amplitude, can lead to propagation.  Ca
2+ is able to pass through gap junctions to 
propagate CICR and thus arrhythmia in the heart as a whole (Barr et al. 1996).   
 
The  likelihood  of  Ca
2+  waves  occurring  in  cardiomyocytes  can  be  increased  by  various 
mechanisms.  As mentioned previously, an abnormally high [Ca
2+] within the SR allows RyRs 
to become ‘leaky’ which can set up the Ca
2+ release necessary for a wave.  But what causes 
SR overloading?  A high extracellular [Ca
2+] leads to inward movement of Ca
2+ through the 
NCX, which in turn causes more Ca
2+ to be taken up by SERCA into the SR.  These events 
occur in diseases such as heart failure, other ischaemic states and digitalis toxicity (Cheng and 
Lederer 2008; Xie and Weiss 2009).  Genetically inherited defects in regions coding for RyRs 
are known causes of excess leakage of Ca
2+ from the SR, and thus arrhythmias in humans (Xie 
and Weiss 2009).   
 
1.1.3 Proteases and PARs 
 
Proteases are ubiquitous hormone-like signalling molecules with wide ranging effects in the 
mammalian body.  Trypanosome species can produce their own proteases which can allow 
them access to the central nervous system, and which play roles in disease pathogenesis and 
parasite growth (Nikolskaia et al. 2006).  Examples are the cathepsin L-like cysteine protease 
‘brucipain’ produced by T. brucei gambiense, ‘rhodesain’ from T. b. rhodesiense and ‘cruzain’ 
produced  by  T.  b.  cruzi.    Indeed  it  is  now  thought  that  brucipain  is  essential  to  T.  b. 
rhodesiense, shown by the failure of RNAi of this protease to produce viable parasites (J. C. E. Walls    0910764w 
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Mottram, pers. Comm.)(Nikolskaia et al. 2006).  Proteases can influence intracellular [Ca
2+] 
through the activation of protease-activated receptors (PARs).   
 
PARs are a family of G-protein coupled, 7-transmembrane helix cell surface receptors, four of 
which have been discovered to date (Hansen et al. 2008).  Genes encoding PARs 1, 2 and 3 
are localized  on  chromosome  5q13,  with  PAR  4  being  structurally  similar  but  located  on 
chromosome 1qp12 (Barnes et al. 2004).  Activation of these receptors can be achieved in two 
ways.  Firstly, proteolytic cleavage of a short amino acid sequence at the extracellular surface 
of  the  molecule  frees  a  tethered  ligand  structure.    This  ligand  is  then  able  to  contact  an 
activation site, leading to a conformational change in the PAR, and a downstream activation 
cascade.  This is an irreversible mechanism, terminating in receptor internalisation (Bohm et 
al. 1996).  No function for the cleaved portion of the PAR has yet been discovered (Barry et 
al. 2006).  Alternatively, short amino acid sequences called PAR-activating peptides (PAR-
APs) are able to mimic the tethered ligand and can reversibly bind directly to the extracellular 
activating domain (Bohm et al. 1996; Hansen et al. 2008).    Studies of the effects of T. cruzi 
on canine cardiomyocytes proved that the receptors involved in the wave response were G-
protein linked, by noting the effect of pertussis toxin (PTx) on wave frequency.  PTx causes 
ADP-ribosylation of some of the G-protein α-subunits which blocks signal transduction.  The 
addition of PTx was able to completely abolished Ca
2+ waves in these studies (Barr et al. 
1996).    Following  activation,  PARs  are  internalised  into  endosomes  and  subsequently 
degraded within lysosomes (Bohm et al. 1996; Trejo 2003; Barry et al. 2006).  Cleavage and 
internalisation of PARs is one mechanism of desensitisation to protease-induced activation, 
but  others  including  receptor  phosphorylation  leading  to  uncoupling  of  G-proteins,  and 
inhibition of downstream signalling events also occur (Bohm et al. 1996).  It has been shown 
that desensitisation occurs within 2 min of stimulation, but also that cells resensitise over a 
period of 30-60 min (Bohm et al. 1996).  This resensitisation is due to mobilisation of stores 
of PAR 2 from post-Golgi organelles initially, followed by stores within the Golgi itself.  If 
further stimulation occurs, the cell must manufacture nascent PAR 2 to replenish cell surface 
stores and remain sensitive (Bohm et al. 1996). 
 
Each  of  the  PARs  discovered  to  date  can  also  be  irreversibly  antagonised  with  known 
molecules,  most  of  which  block  activation  by  cleavage  of  the  tethered  ligand  from  the 
receptor, thus rendering the PAR unable to ‘self-activate’.  However, PAR-APs can overcome C. E. Walls    0910764w 
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this inactivation by binding directly to the extracellular binding site.  Alternatively, cleavage 
of one of the exposed portions of a transmembrane loop leads to receptor inhibition (Barry et 
al. 2006).   
 
 
Figure 1.2 Diagrammatic representation of PAR activation by a protease.  Signal transduction 
begins with G-protein activation.  Adapted from a diagram from Critical Care Forum Online 
(www.ccforum.com). 
 
PARs are distributed throughout the body and can be responsible for very varied, occasionally 
antagonistic actions.  For instance, activation of PAR 1 can lead to analgesic effects, whereas 
PAR  2  has  been  implicated  in  producing  pro-algesic  effects.    PAR  functions  include  the 
modulation  of  nociception,  platelet  activation,  maintenance  of  vascular  tone, 
bronchospasm/relaxation and inflammation (Sambrano et al. 2000; Barnes et al. 2004; Asfaha 
et al. 2007; Dale and Vergnolle 2008; Hansen et al. 2008; Pinet et al. 2008).  PAR 2 is thought 
to be the receptor which is involved in the Trypanosome wave response (Grab et al. 2009).  
Activation of PAR 2 leads to the activation of Phospholipase C (PLC), with the subsequent 
production  of  inositol-1,4,5-triphosphate  (IP3)  and  diacylglycerol  (DAG)  from 
phosphatidylinositol-4,5-biphosphate (PIP2).  IP3 would then be free to bind to its receptors on 
the SR, initiating release of Ca
2+ from intracellular stores.  Indeed, it has been shown that IP3 
and PLC are found  at  higher concentrations in cells exposed to Trypanosome supernatant 
(Barr et al. 1996; Grab et al. 2009).  This increase in intracellular [Ca
2+]
 could predispose the 
SR to overloading, and thus increase the likelihood of Ca
2+ wave formation. 
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Table 1.1 Endogenous activators, activating peptides and inhibitor molecules active against 
each protease-activated receptor (Trejo 2003; Barry et al. 2006; Ramachandran and 
Hollenberg 2008; Strande et al. 2008). 
PAR Type  Activators  PAR-APs  Inhibitors 
PAR 1  Thrombin  SFLLRN  SCH-203099 
  Cathepsin-G  SFFLRN  SCH-205831 
      SCH-5303048 
      ER-112787 
      BMS-200261 
      RWJ-56110 
      RWJ-58259 
PAR 2  Trypsin  SLIGRL  ENMD-1068 
  Tryptase  SFLLRN   
  Factor Xa  SLIGKV   
    2-furoyl-LIGRLO   
PAR 3  Thrombin     
PAR 4  Thrombin  GYPGQV  Trans-cinnamoyl-YPGKF 
  Trypsin  GYPGKF  P4pal-10 
  Tryptase  AYPGKF   
  Cathepsin-G     
 
1.1.4 iRAS Theory 
 
Proteases might alternatively lead to Ca
2+ waves through activation of the intracellular Renin-
Angiotensin-Aldosterone (iRAS) system.  All of the components of this system can be found 
in cardiomyocytes, albeit at low levels physiologically (Kumar et al. 2008).  Cathepsins can 
activate  the  production  of  intracellular  Angiotensin  II  which  leads  to  an  increase  in  Na
+ 
extrusion, which in turn could increase the influx of Ca
2+ ions via the NCX (Gavras and 
Gavras 2002; Iravanian and Dudley, Jr. 2008).  Increase in Angiotensin II has also been shown 
to increase AP duration and repolarisation dispersion, which are known to be arrhythmogenic 
(Perrier et al. 2005; Iravanian and Dudley, Jr. 2008; Kurokawa and Abriel 2009).  The pro-
arrhythmic effects of Aldosterone include increase in the Ca
2+ influx size, longer AP duration 
and an increase in the expression of L-type Ca
2+ channels (Perrier et al. 2005; Kurokawa and 
Abriel  2009).    Overall,  the  effect  of  activating  iRAS  in  the  heart  is  to  produce  cardiac 
hypertrophy and fibrosis (Gavras and Gavras 2002).   Investigation of this hypothesis was 
beyond the scope of this study.     
 
It is hypothesised that the Trypanosome product causing the Ca
2+ wave response in adult rat 
cardiomyocytes  is  a  cathepsin  L-like  protease,  which  interacts  with  PAR  2  receptors  on 
cardiomyocytes leading to wave formation (Nikolskaia et al. 2006; Grab et al. 2009).  In this C. E. Walls    0910764w 
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study, the ability to block this action with a known irreversible inhibitor was used to study the 
effects on spontaneous wave production.  K11777 is an irreversible cathepsin L-like cysteine 
protease inhibitor, known to inhibit the crossing of human brain microvascular endothelial 
cells (HBMECs), (a human BBB model system) by T. b. gambiense (Nikolskaia et al. 2006).   
 
This study had two overall aims; a) to investigate the effects of the cathepsin L-like protease 
inhibitor K11777, and thus determine whether a cathepsin L-like protease product produced 
by  Trypanosoma  was  the  cause  of  increased  Ca
2+  waves,  and  b)  to  utilize  the  PAR-AP 
SLIGRL-NH2 to determine whether PAR 2 may be involved in spontaneous wave production 
of isolated adult rat cardiomyocytes.  
 
1.2 Materials and Methods 
 
1.2.1 Cell Isolation 
 
Adult  male  Wistar  rats  (225-300  g)  were  euthanized  via  a  Schedule  One  procedure  in 
accordance  with  the  UK  Animals  (Scientific  Procedures)  Act  1986.    Hearts  were  quickly 
excised and placed into ice cold Krebs and gently squeezed to expel the majority of blood.  
Any  extraneous  tissues  were  rapidly  dissected  away,  the  aorta  isolated,  and  the  hearts 
weighed.  Hearts were rapidly cannulated onto a Langendorff retrograde perfusion system via 
the aorta, and secured in place.  All solutions perfusing the heart were maintained at 37.0-
37.5
0C using a water bath, and the rate of perfusion was maintained at 6 ml/min.  The hearts 
were perfused with Krebs solution (see composition below) for 5 min to flush out all residual 
blood.  After this time, the hearts were perfused for 10 min with Krebs solution supplemented 
with 0.83 mg ml
-1 Collagenase and 8.3 µg ml
-1 Protease.  Finally BSA solution at 6.5 mg ml
-1 
was perfused for 3 min 20 s.  Following this perfusion, the hearts were submerged in warm 
BSA, the atria and right ventricle dissected  away, and the  remaining tissue dissected into 
small, roughly uniform pieces.  The tissue pieces were gently agitated in BSA for on average 
15 mins to yield a single cell suspension.  The [Ca
2+] of the cell suspension was increased in 
stepwise increments to a final concentration of 1 mM for Trypanosome experiments, or 1.4 
mM for PAR-AP experiments.  The cells were allowed to settle into a pellet by gravity before 
being resuspended in HBK solution. 
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1.2.2 Solutions 
 
All solutions were prepared freshly on the day of an experiment, with pH corrected at room 
temperature.  All concentrations are in mmol/L unless stated otherwise. 
 
Base Krebs -  120 NaCl, 20 HEPES, 5.4 KCl, 0.52 NaH2PO4, 3.5 MgCl26H2O, 20 Taurine, 10 
Creatine, 11.1 glucose anhydrous, adjusted to pH 7.68. 
 
Enzyme solution – Base Krebs supplemented with 0.83 mg ml
-1 Collagenase (Type 1, Sigma 
Chemical) of activity 316 u mg
-1, and 8.33 µg ml
-1 Protease (Type XIV, Sigma Chemical) at 
4.8 u mg
-1 activity.   
 
BSA solution – Base Krebs supplemented with 6.5 mg ml
-1 BSA (Sigma Chemical).   
 
Calcium - The Ca
2+ concentration was varied in the isolated cell suspensions by adding known 
volumes of 1 M CaCl2 solution (BDM).   
 
Mock extracellular solution (termed HEPES Base Krebs (HBK)) -  was used to resuspend 
isolated heart cells before commencing population studies, its composition was as follows 
(mM): 140 NaCl, 4 KCl, 1 MgCl2, 5 HEPES, 11.1 glucose anhydrous, 1 CaCl2, adjusted to pH 
7.4. 
 
K11777 was a kind gift from Professor Jeremy Mottram. 
 
PAR-AP - The PAR-AP SLIGRL-NH2 (Tocris biosciences) was introduced to cell 
suspensions by adding known volumes of 10 M solution.  
 
1.2.3 Trypanosoma species   
 
Populations of Trypanosoma brucei brucei strain Lister 427 were maintained axenically in 
logarithmic growth phase in a modified version of HMI9 medium (Hirumi and Hirumi 1994), 
the medium that is widely used to culture bloodstream (mammalian form) trypanosomes. The 
modified  recipe  is  as  follows  (P.  Voorheis,  pers.  comm.):  IMDM  (Iscove’s  Modified C. E. Walls    0910764w 
23 
 
Dulbecco’s  Medium,  Invitrogen)  supplemented  with;  1  mM  hypoxanthine,  50  µM 
bathocuproinedisulfonic acid, 1.5 mM cysteine, 2 mM sodium pyruvate, 160 µM thymidine, 
200  µM  2-mercaptoethanol,  1.4  mM  glucose,  125  µM  adenosine,  125  µM  guanosine,  30 
µg/ml kanamycin, 1 mg/ml methyl cellulose. Parasites were cultured in HMI9 with 20% v/v 
Serum Plus, a serum supplement containing Foetal Bovine Serum (SAFC Biosciences) in a 
humid  incubator  at 37°C,  5%  CO2.  Counting  of  parasites  was done  in  triplicate  using  an 
improved  Neubauer  Haemocytometer.  Supernatant  was  prepared  by  spinning  cultured 
trypanosomes at 857 g for 10 min, and the supernatant was subsequently removed by pipette. 
To ensure there was no contamination with live trypanosomes, supernatant was further filtered 
using a 0.2 µm syringe filter (Sartorius Stedim). Control medium was treated in an identical 
manner to the supernatant (spun and filtered). Inhibitor K11777 was added after spinning and 
filtration, at a concentration of 10 µM. 0.1% DMSO was added to no-inhibitor controls. Live 
parasites were re-suspended in approximately 10 ml of medium and recounted in triplicate 
using  the  improved  Neubauer  Haemocytometer.  Suspensions  of  parasites  and  removed 
supernatant were adjusted to the pH of the control HMI9 batch used for each experiment. 
 
1.2.4 Data Recording - Population Studies 
 
Baseline spontaneity of cardiomyocytes was assessed by microscopic ‘population studies’ of 
the incidence of waves produced over 60 s by rod-shaped (‘live’) cardiomyocytes over ten 
microscope  fields  at  the  10X  objective.    Samples  of  the  cardiomyocytes  in  HBK  were 
incubated for 30 min at room temperature with supernatant or growth media, with or without 
K11777 added.  Population studies were performed to compare the spontaneous wave activity 
of cardiomyocytes when exposed to Trypanosoma supernatant, or growth media.  The effect 
of adding the inhibitor K11777 was assessed, and appropriate control solutions were also used.  
All population studies were controlled for suspension pH and time.  Control solutions for 
K11777 were media plus the equivalent volume of vehicle (DMSO).  Chi-square tests were 
used where appropriate to assess differences in wave production. 
 
1.2.5 PAR-AP Experiments 
 
PAR-AP experiments were conducted after raising the [Ca
2+] of cell suspensions to 1.4 mM 
and assessing baseline spontaneity initially.  Known volumes of 10 M SLIGRL-NH2 were C. E. Walls    0910764w 
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incubated with cardiomyocytes for either 5 min or 30 min, and effects on spontaneous wave 
production recorded. 
 
1.3 Results 
 
The weight of the adult rat hearts used was 1.54 g ± 0.422 g.  Following isolation of a suitable 
population of live (‘rod form’) adult rat cardiomyocytes, the proportion of cells exhibiting at 
least one Ca
2+ wave over 60 seconds was recorded as a proportion of total live cells, for ten 
fields at the 10X objective (‘baseline spontaneity’).  Cell suspensions containing growth media 
with  either  DMSO  or  K11777,  in  the  absence  of  supernatant,  produced  a  level  of  wave 
production which was not significantly different from the baseline measure.  Wave production 
in cell suspensions with supernatant, but not K11777, was significantly increased above all 
other suspensions.  Upon addition of K11777 to those cell suspensions containing supernatant, 
wave production occurred in a similar proportion of cardiomyocytes to baseline and media 
suspensions.  
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1.3.1 Inhibitor K11777  
 
 
Figure 1.3 Comparison of wave incidence over 60 s with combinations of growth media, 
supernatant  and  cathepsin  L-like  cysteine  protease  inhibitor  K11777.    Cardiomyocyte 
suspensions were incubated with each solution for 30 min prior to wave assessment. (* p < 
0.05).  Supernatant produced a predictable rise in wave production.  Introduction of K11777 
reversed this trend back toward baseline, n=5. 
 
1.3.2 PAR-AP Experiments 
 
As  Figure  1.4  shows,  no  significant  alterations  in  wave  production  were  seen  following 
addition of the PAR 2 activating peptide SLIGRL-NH2 at 10 µM, 100 µM, 300 µM, or 600 
µM at any time.  Extended incubation times of 30 min failed to produce any alteration in wave 
production.  Incidence of waves in cell suspensions devoid of any Trypanosome product or 
medium remained the same over the period of the experiments (approx. 5 hrs), thus ageing 
change or time-dependant degradation of cardiomyocytes was not responsible for any of the 
results produced. 
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Figure 1.4 Comparison of wave production after incubation of isolated cardiomyocytes with 
varying concentrations of SLIGRL-NH2 for (i) 5 min or (ii) 30 min.  No concentration of 
SLIGRL-NH2  produced  an  increase  in  wave  incidence  at  any  time.    No  appreciable 
degradation in cardiomyocytes was observed over time, as shown by the similarity in wave 
incidence at the beginning and end of the experiment. 
 
1.4 Discussion 
 
Barr et. al discovered that the presence of Trypanosoma cruzi supernatant caused a significant 
increase in the occurrence of diastolic Ca
2+ waves in isolated adult cardiomyocytes (Barr et al. 
1996).  This phenomenon was also observed using other Trypanosome species.  It was thought 
that the cause of this effect was excretion/secretion of a protease product from the parasite into 
the surrounding medium.  Trypanosomes of various species are known to employ protease 
excretions in pathogenic mechanisms for invasion and adhesion.  Indeed, it seems likely that 
invasion  of  the  CNS and thus  the  major  morbidity  caused  by  T.  brucei species  is  due to 
production of a cysteine protease which disrupts the normal Ca
2+ handling of the cells of the 
BBB (Nikolskaia et al. 2006).  In this study we demonstrate that the protease produced by T. 
b. brucei, a closely related organism to the causative agents of HAT, is a cathepsin L-like C. E. Walls    0910764w 
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cysteine protease, whose effects on isolated cardiomyocytes can be abrogated by addition of 
the inhibitor K11777.   
 
Sabri et. al. showed that IP3 production is altered by the addition of the PAR-AP SLIGRL-
NH2 after 5 min at a concentration of 300 µM (Sabri et al. 2000).  This study set about to 
assess the effects of this peptide on wave production in a time and concentration dependant 
manner.  Although a small increase in wave production was observed above baseline in those 
experiments using 300 µM peptide, this was not significant.  The inherent sensitivity of the 
aforementioned population studies to detect PAR activation is low.  Also it is unknown what 
proportion of Ca
2+ handling in adult cells is due to IP3 production rather than RyRs, compared 
with neonatal cardiomyocytes.  These factors taken together imply that the failure to see any 
alteration in wave production using PAR-APs, does not necessarily mean that PAR 2 is not 
involved.   Rather, it  suggests  that more  sensitive  techniques  such  as  single  cell  perfusion 
techniques and IP3 assays may be of benefit in future. Repetition of these experiments and use 
of the reverse peptide LRGILS-NH2 was beyond the scope of this study. 
 
HAT  is  an  infectious  disease  of  major  importance,  whose  main  pathogenesis  lies  in  the 
neurological damage caused by entry into the CNS of the causative organism.  A significant 
contributor to this disease picture is the cardiovascular derangement seen in the majority of 
HAT  cases (Blum et  al.  2006).    The  arrhythmogenic  potential  of  Trypanosomiasis comes 
further  into  focus  when  novel  drug  therapies  are  themselves  a  cause  of  cardiac  rhythm 
disturbance.  Although not usually fatal alone, if Trypanosomiasis arrhythmias are worsened 
by drug therapy, death through heart failure becomes a possibility.  Current drug treatments 
for  both  first  and  second  stage  HAT  carry  a  high  degree  of  toxicity,  are  not  completely 
effective, have complicated and lengthy administration regimens, and have conferred some 
degree  of  drug  resistance  within  parasite  populations  (www.who.int  2010).    Active 
investigation into possible new therapies is being undertaken in the hope that they will yield 
higher efficacy with lower toxicity among patients. 
 
Protease  inhibitors  are  currently  used  as  treatments  for  diseases  such  as  HIV,  parasitic 
infections  such  as  Giardiasis,  and  neoplasia.    One  of  the  difficulties  in  producing 
pharmacologically effective protease inhibitors lies in targeting only the pathogenic uses of 
proteases,  and  sparing  those  physiological  functions  which  may  be  many  and  diverse.  C. E. Walls    0910764w 
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Cathepsin L-like molecules are ubiquitous in the mammalian body, making drug targeting a 
difficult but crucial stage in development.   
 
Ca
2+ handling appears to be central to the mechanism of CNS invasion employed by those 
species of Trypanosomes whose life-cycle includes such a stage  (Nikolskaia et al. 2006).  It is 
not known exactly how this alteration in Ca
2+ handling allows penetration beyond the BBB, 
but it is clear that cysteine proteases are involved (Nikolskaia et al. 2006).  It remains to be 
seen whether the same papain-like cysteine protease which causes BBB traversal, also causes 
cardiac arrhythmias.  The implications would be that a common novel drug therapy may be 
able to prevent both the neurological, and the cardiac manifestations of HAT, by inhibiting the 
action of the particular cysteine protease involved.   
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CHAPTER 2 - The Changing Profile of Equine Disease in Great 
Britain from the 1960s to the 1990s 
 
Abstract 
Two survey-based  studies  of  equine  disease  in the  UK  gathered  thirty  years 
apart were compared on the basis of disease category  prevalence.   The first 
study,  published  in  1965,  was  conducted  by  the  British  Equine  Veterinary 
Association and covered the whole of mainland UK and Ireland.  The second 
dataset was obtained from The Home of Rest for Horses Study, which surveyed 
Scotland  and  northern  England  in  the  mid-1990s.    Musculoskeletal  and 
alimentary  diseases  were  the  most  important  categories  of  disease  in  both 
studies, but there were significant differences seen in both the composition of 
the horse population in terms of breed type, and the profile of disease between 
the studies.  The predominant horse type in the BEVA study was the pony, 
whereas the HRH study reported a more even distribution of ponies, hunter-type 
horses and racehorses within the population.  Disease categories which were 
more  commonly  diagnosed  in  the  HRH  versus  the  BEVA  study  included 
musculoskeletal and systemic disease.  Those categories which had were less 
commonly diagnosed comprised alimentary and respiratory disease.   
 
2.1 Introduction 
 
Professional  and  recreational  equestrianism  are  popular  pursuits  within  the  UK.    Studies 
estimate that the current number of horses in Great Britain lies between 600,000 and 1 million 
(Mellor et al. 1999; E.J.Leckie 2001; BHIC Ltd. 2009).  It is estimated that up to 270,000 
people are directly or indirectly employed in equestrianism and associated support industries, 
which have an annual turnover (all sources of revenue combined) in the region of £3.4 billion 
(BHIC Ltd. 2009).  The Animal Welfare Act 2006 dictates that owners and carers of equines 
in the UK have a legal responsibility to safeguard their welfare.  Knowledge of population 
disease status and how it has changed over time in association with trends in management and 
treatment would be useful and informative to help improve future equine welfare.  Reliable 
population data is necessary to allow robust epidemiological studies to inform on the control C. E. Walls    0910764w 
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and prevention of disease.  Currently there is no such information available for the UK herd as 
a whole. 
 
In 1997 Mellor et al. published results from a three year study which set out to define the size 
and demographics of the horse population of Scotland and northern England, along with the 
prevalence of diseases occurring over a one-year period as seen by first opinion veterinarians 
(HRH study).  A study conducted by the British Equine Veterinary Association (BEVA) in the 
early 1960s recorded similar information on disease occurrence in horses in England, Scotland 
and Ireland, also over a one year period (BEVA study).  These studies stand alone as the only 
large-scale investigations into disease prevalence within a proportion of horses in the UK.  
The aim of this paper was to compare these datasets to discover what, if any, changes had 
occurred in disease prevalence over the thirty years between the BEVA and HRH studies.   
 
2.2 Materials and Methods 
 
2.2.1 BEVA Study 
 
During the British Equine Veterinary Association Survey of Equine Disease, BEVA members 
from 70 practices and clinics across Scotland, England and Ireland were asked to provide 
monthly feedback detailing every case of equine disease attended over the period from June 
1962 to May 1963, and to state the number of horses under the care of their practice.  Returns 
were grouped into four geographical areas: the ‘North’ including Scotland and England as far 
south as Hull and Liverpool, the ‘Midlands’ extending from the North region to Bristol and 
Colchester, the ‘South’, and Ireland.  The published data comprised lists of diagnoses, grouped 
into thirteen disease categories, for which the number of cases reported in racehorses, hunters, 
ponies and heavy horses were included.  The authors did not draw any conclusions from the 
data  in  the  publication.    The  methods  of  data  collection  and  categorisation  into  disease 
groupings or breed type were not stated in the paper, and did not exist in any linked resources, 
such that the robustness and reliability of the figures stated could not be assessed. 
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2.2.2 HRH Study 
 
The Home of Rest for Horses, founded in 1886, is a charitable organisation concerned with 
equine  welfare  issues.    In  the  1960s  the  organisation  began  making  grants  to  veterinary 
practices and universities to fund capital building projects and research designed to benefit 
equine health and welfare.  Unsurprisingly, much of the research on equine health and disease 
was  conducted  in  University  teaching  hospitals,  whose  case  load  is  not  necessarily 
representative  of  that  of  the  general  equine  population.    In  the  1990s  it  was  agreed  that 
obtaining  detailed  survey-based  information  on  the  health  and  husbandry  of  the  general 
population  of  horses  would  benefit  all  equidae,  by  revealing  areas  of  horse  care  which 
required further research.  To this end, The Home of Rest for Horses funded a project to 
collect and analyse data on the total size, composition and geographical distribution of the 
equine population of Scotland and northern England.  In addition, data were gathered on the 
management, activity level and disease prevalence of horses in the area.  The study began in 
October 1992 and used a sentinel practice-based approach to data gathering.  Four surveys of 
specifically recruited first opinion veterinary practices were conducted.  The detailed design of 
the survey programme is given in Mellor et al. (1999).  For the collection of disease diagnosis 
data, 25 randomly chosen veterinary practices, from a census of all veterinary practices in 
Scotland and Northern England involved in equine work, were invited to be sentinel practices.  
Individual clinicians within each practice agreed to complete and return ten specially designed 
‘case sheets’ on a quarterly basis for one year, for the first ten equine animals attended for 
whatever reason each time after receiving the blank cases sheets in the mail.  Sets of ten case 
sheets were mailed to each veterinarian during August and November 1994 and February and 
May 1995 with a reply paid envelope for return once completed.   Case sheets recorded details 
of the signalment and anamnesis of the animal, the clinical signs noted, presumptive diagnosis, 
and details of treatment, management and prognosis as appropriate.  Data from completed 
useable case sheets were entered into a specifically designed Microsoft Access (Microsoft 
Corporation) database using a standardised classification of clinical signs and diagnoses in use 
by the equine hospital at the University of Glasgow at the time.  Disease diagnoses were 
subsequently classified into disease categories, largely relating to the body system affected, by 
the authors.    
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2.2.3 Comparison of BEVA and HRH Studies 
 
For the present study, data listed in the ‘British Equine Veterinary  Association Survey of 
Equine  Disease  1962-63’  (COOK  1965)  were  manually  entered  into  a  spreadsheet  in 
Microsoft Excel (Microsoft Corporation).  Using the existing electronic database in Microsoft 
Access compiled during the HRH study, all case reports were reassigned to one of thirteen 
categories  of  disease  as  dictated  in  the  BEVA  study,  in  order  that  the  datasets  could  be 
compared directly.  Breeds of horse in the HRH study were grouped into ‘racehorse’, ‘hunter’, 
‘heavy horse’ or ‘pony’ types, as used in the BEVA study.  All cases described as being 
‘routine’ such as pregnancy diagnosis and vaccinations were removed from the HRH study 
database, along with any repeated visits to the same animal to avoid replication.  Other cases 
excluded  from  analysis  were  those  reporting  ‘no  abnormality  detected’,  and  cases  from 
donkeys.  Where no breed was recorded for a case in the HRH dataset, or where the breed was 
denoted as ‘other’ (a total of 9 cases out of 294, 3.1%), the case was assigned to the hunter 
category.   
 
Following  reclassification  and  preparation  of  the  available  data,  comparisons  of  horse 
population  data  were  performed  using  chi-square  analyses  in  Minitab  (Minitab  Statistical 
Software  Version  15).    Crude  period  prevalence  was  calculated  for  each  classification  of 
disease in both studies, with confidence intervals for each result using an online adjusted-
WALD  asymmetric  interval  calculator  (www.measuringusability.com).    The  prevalence  of 
each  disease  classification  within  each  horse  type  was  also  found.    Where  no  overlap  of 
confidence intervals occurred between paired proportions, the difference was considered to be 
significant.    As  appropriate,  chi-square  tests  were  used  in  Minitab  version  15  Statistical 
Software Package to test the significance of changes in apparent disease prevalence between 
the two studies. 
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Table 2.1  All breeds of horse recorded in the HRH study were assigned to one of four ‘types’ 
as shown below.  Horses recorded as ‘other’, or where breed was not recorded, were included 
in the Hunter type. 
Breed Classification Group 
Racehorse  Hunter  Pony  Heavy Horse 
Standardbred  Andalusian  Connemara  Clydesdale 
Standardbred X  Anglo Arab  Connemara X  Clydesdale X 
Thoroughbred  Appaloosa  Dales  Irish Draught 
Thoroughbred X  Arab  Dartmoor  Shire 
  Arab X  Exmoor  Shire X 
  Cleveland Bay  Fell   
  Cleveland Bay X  Highland   
  Cob  Highland X   
  Cob X  New Forest   
  Eventer  Pony   
  Hack  Shetland   
  Haflinger  Shetland X   
  Hanoverian  Welsh   
  Hanoverian X  Welsh X   
  Hunter     
  Part Bred     
  Quarter Horse     
  Quarter Horse X     
  Show Jumper     
  Trakehner     
  Warmblood     
  Warmblood X     
 
Table 2.2  Example diagnoses from the BEVA study within the thirteen categories of disease. 
Disease Classification  BEVA Study Example Diagnoses 
Musculoskeletal  Fractures, Ringbone, Laminitis, Sandcracks 
Alimentary  Helminthiasis, Colic, Hernia, Gingivitis 
Urogenital  Anoestrus, Abortion, Retained Placenta 
Respiratory  Strangles, Laryngeal Hemiplegia, Influenza 
Skin  Dermatitis, Ringworm, Photosensitisation 
Nervous  Head Shaking, Encephalitis, Facial Paralysis 
Blood & Lymphatic  Azoturia, Lymphangitis, Septicaemia 
Neoplasia  Melanoma, Carcinoma, Teratoma,  
Cardiovascular  Pericarditis, Iliac Thrombosis 
Systemic Disease  Tetanus, Brucellosis, Hyperthyroidism 
Mammary Gland  Mastitis 
Eye  Keratitis, Conjunctivitis, Cataract 
Ear  Otitis 
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2.3 Results 
 
2.3.1 BEVA Study Results Summary 
 
The results of the BEVA study were published in 1965 (COOK 1965).  Briefly, they were 
summarised  as  follows:  in  total  43,538  horses were  registered  with  responding  veterinary 
practices,  and  17,268  cases  of  disease  were  reported.    Musculoskeletal  disease  was  the 
commonest  category  of  disease  reported  (6588),  followed  by  alimentary  (4441),  and 
urogenital (2434) conditions.  The least commonly reported category was ear disease, with 
only 7 cases.  The authors concluded that there was no seasonal or regional bias in terms of 
reported disease incidence.   
 
2.3.2 HRH Study Results Summary 
 
Some  results  from  the  HRH  study  have  been  published  previously,    but  the  disease  data 
presented here have not (Mellor et al. 1999; Mellor et al. 2001).  Briefly: seven hundred and 
sixty case sheets were mailed to the 19 sentinel veterinary practices which had agreed to take 
part.  Twelve practices each returned a full complement of 40 case sheets, and 3 practices did 
not respond despite previously agreeing their involvement.  Response rates were similar for all 
four seasons.  Some case sheets were returned blank or unusable, and 20 case sheets were for 
repeated visits to individual horses.  In total, 547 case sheets were returned and useable from 
16 sentinel practices.  One hundred and seventy eight routine consultations were documented, 
accounting  for  33%  of  cases.    Musculoskeletal  disease  was  the  most  prevalent  disease 
category, accounting for 28% of all cases seen, followed by alimentary disease (13%) and skin 
disease (9%) (see Fig. 2.2).   
 
2.3.3 Results of Comparison of BEVA and HRH Studies 
 
The geographical extent of the ‘North’ region of the BEVA study approximated that of the 
whole HRH study.  The BEVA study used the number of horses registered with responding 
veterinary practices to estimate the size of the horse population at that time, whereas the HRH 
study used the number of horses owned by responding clients.  While the derivation of these 
estimates  differed,  it  was  thought  reasonable  to  use  both  to  estimate  changes  in  the C. E. Walls    0910764w 
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demographics of the equine population.  When data from the North region of the BEVA study 
were compared with the HRH data, the representation of each horse type differed significantly 
between  the  studies  (p<0.001).    The  BEVA  study  (North)  reported  that  60%  of  animals 
registered were ponies, 23% were hunters, 13% were racehorses and 4% were heavy horses.  
In contrast, horses owned in the HRH dataset comprised the following: 33% ponies, 31% 
racehorses, 28% hunters and 8% heavy horses. 
 
 
Figure 2.1 The composition of the equine population of northern Britain in 1965 and in 1997, 
where a. represents the BEVA (North) study (n=13,960) and b. the HRH study data (n=1252).  
 
For each study, the proportions of each horse type seen by veterinarians were ranked.  In both 
studies,  hunters  contributed  most  case  reports  followed  by  racehorses,  ponies  and  finally 
heavy horses (see Table 2.3). 
 
Table 2.3 Each horse type in the BEVA and HRH Studies ranked by their relative abundance 
in the ‘population’ at the time of each study, and by the relative proportion of veterinary case 
reports from each horse type. 
  BEVA Study  HRH Study 
Rank Position 
Relative 
Population Size 
Contribution to 
Case Reports 
Relative 
Population Size 
Contribution to 
Case Reports 
1  Ponies  Hunters  Ponies  Hunters 
2  Hunters  Racehorses  Racehorses  Racehorses 
3  Racehorses  Ponies  Hunters  Ponies 
4  Heavy Horses  Heavy Horses  Heavy Horses  Heavy Horses 
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Table  2.4  The  number  of case  reports  of  each  disease  category in  each  study, with their 
relative proportions. 
Disease Category 
BEVA Study  HRH Study 
Number of 
Cases 
% 
Number of 
Cases 
% 
Musculoskeletal  6588  41.2  164  55.8 
Alimentary  4441  27.8  39  13.3 
Urogenital  1138  7.1  19  6.5 
Respiratory  1776  11.1  22  7.5 
Skin  935  5.9  26  8.8 
Blood & Lymphatic  306  1.9  4  1.4 
Neoplasia  226  1.4  4  1.4 
Cardiovascular  185  1.2  0  - 
Eye  149  0.9  3  1.0 
Systemic  140  0.9  12  4.1 
Nervous  54  0.3  0  - 
Mammary Gland  27  0.2  1  0.3 
Ear  7  0.0  0  - 
 
Analysis  of  the  six  most  prevalent  disease  classifications  (with  all  other  classifications 
amalgamated into a seventh category) revealed a significant alteration in the pattern of disease 
categories  reported  between  the  studies  (p<0.001).    Musculoskeletal  disease  formed  the 
majority  of  cases  seen  in  both  the  BEVA  and  HRH  studies.    Between  the  studies,  the 
proportion of all diagnoses which reported musculoskeletal disease increased (41.2 ± 0.8% to 
55.8 ± 5.7%).  Systemic disease also increased in proportion from the BEVA to the HRH 
study (0.9 ± 0.1% to 4.1 ± 2.3%).  Other significant changes comprised a fall in alimentary 
disease diagnosis proportion (27.8 ± 0.7% to 13.3 ± 3.9%), and a fall in respiratory disease 
diagnosis proportion (11.1 ± 0.5% to 7.5 ± 3%).  No cases of cardiovascular, nervous or ear 
disease were reported in the HRH study.  No other disease categories altered in proportion 
when all horse types were considered together.   
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Figure 2.2 Comparison of the number of diagnoses of each disease category as a percentage 
of all diagnoses in each study.  Error bars indicate 95% confidence intervals. (* indicates 
significance as defined by non-overlapping confidence intervals). 
 
2.4 Discussion  
 
In summary this study found that the demographics of the horse population of Scotland and 
northern England altered significantly during the period between the 1960s and 1990s, as did 
the reported prevalence of the disease categories featured.  Ponies were the most abundant 
equine type in northern Britain in the BEVA study, whereas the HRH study showed a more 
even  distribution  of  animals  between  the  pony,  hunter  and  racehorse  categories.    Despite 
ponies  being  the  most  abundant  horse  type  in  both  studies,  hunters were  more frequently 
attended by veterinarians.  The reporting of musculoskeletal and systemic diseases appeared to 
increase, while reports of alimentary and respiratory diseases became less common over the 
time period between studies. 
 
These two studies represent the only two in recent times that have attempted to describe the 
disease profile of the general equine population of a significant part of the UK.  Although the 
HRH study contains relatively few case records compared to the BEVA study, the data are 
valuable and make interesting comparisons in terms of major trends.  Comparisons between 
the studies are only made at the disease category level as consistency of diagnosis below this 
level would make such comparisons subject to bias.   
 
Currently, there exist two forms of ‘surveillance’ of the UK equine population, namely the 
National  Equine  Database  (www.nedonline.co.uk),  and  the  Animal  Health  Trust  quarterly C. E. Walls    0910764w 
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disease reports (www.aht.org.uk/equine_disease.html).  The National Equine Database (NED) 
Ltd is an organisation supported and guided by the British Equine Federation (BEF), which 
was set up in 2006 to allow collation, storage and supply of information on every equine born 
in the UK which has a passport.  NED stores information on the name, age, gender, height, 
colour, pedigree and performance of each animal listed, and allows free access of the public to 
much of this information.  NED could not be used in this analysis as it would have excluded 
those horses without passports, and no information on disease is recorded in the database. 
 
The Animal Health Trust (AHT) in collaboration with the Department for Environment, Food 
and Rural Affairs (DEFRA) and the British Equine Veterinary Association (BEVA) began 
collating information on the occurrence of equine disease in the UK in 2004, and publishes a 
report on a quarterly basis.  Disease incidence information is collected from various diagnostic 
laboratories and veterinary practices throughout the country.  The AHT state that bias may be 
a feature of the data in these reports due to the differing motivations of owners in seeking 
veterinary attention.  Although a useful resource, these reports do not assess the prevalence of 
non-infectious  disease,  nor  do  they  give  information  about  the  location  of  the  veterinary 
practices involved, and as such could not be used in this analysis. 
 
There is a degree of inherent systematic error involved when horse breeds are grouped crudely 
into ‘types’.  The racehorse and hunter type categories used in the BEVA study imply the 
nature of activity undertaken by an animal, rather than its phenotypic appearance or breed, and 
provide  no  middle  ground  for  horses  used  in  multiple  pursuits.    The  main  type  of  work 
undertaken  by  each  horse  in  the  HRH  study  is  not  known  for  the  animals  presenting  to 
veterinarians, thus breed was used as a proxy for usage to enable reclassification, with the 
caveat  that  these  groupings  are  rudimentary  at  best.    The  hunter  category  was  the  most 
prevalent among HRH cases (108/294, 36.7%) and contained the greatest diversity of breeds, 
and therefore was thought the most appropriate group in which to place horses whose breed 
was unknown.   
 
The  majority  of  disease  categories  did  not  appear  to  alter  in  their  contribution  to  overall 
disease diagnoses between the BEVA and HRH studies, namely mammary, neoplastic, blood 
and lymphatic, cardiovascular, nervous, urogenital, skin, eye and ear diseases.  However, for 
some  of  these  categories  no  cases  were  recorded,  therefore  their  ‘prevalence’  cannot  be C. E. Walls    0910764w 
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commented upon with certainty.  Musculoskeletal disease was the most frequently diagnosed 
category  in  both  studies,  followed  by  alimentary  disease.    Although  the  proportion  of 
diagnosed systemic disease appeared to increase between the studies, only a small number of 
case records of this category were available, thus no conclusions can be reliably drawn from 
this result.   
 
The most commonly occurring horse types in the ‘population’ of both studies were not the 
type  most  likely  to  receive  veterinary  attention.    Excluding  heavy  horses  which  were 
consistently few in number, the makeup of the remainder of the equine population in the 1960s 
and 1990s differed significantly.  Ponies were the most abundant of the four horse types at the 
time of the BEVA study, and hunters were the most abundant type during the HRH study.  
Despite these differences, a defined ‘hierarchy’ of horse types emerged when the numbers of 
case reports for each type were compared and this hierarchy was identical in both studies.  In 
both studies, ponies were the most abundant horse type in the population, but they were only 
the third most likely type to receive veterinary attention.  This discrepancy could reflect the 
relative disease resistance of ponies compared with other types of horse, differences in the 
intensity or type of exercise to which ponies are subjected, or potentially a neglect of their 
requirement  for  veterinary  assistance  in  some  circumstances.    Hunters  received  the  most 
veterinary attention, followed by racehorses, irrespective of their numbers in the population. 
 
In the years following the BEVA study, the socioeconomic status of the average person in the 
UK improved.  The proportion of the population falling within the age group thought most 
likely  to  participate  in  equestrian  activities  increased  by  2.5%  between  1981  and  1991 
(Suggett  1999).    During  the  1990s  inflation  began  to  decline,  the  GDP  stabilised, 
unemployment dropped, and an increase was seen in spending on recreation, probably as a 
function of increased disposable income (Suggett 1999).  Owning a horse therefore became 
financially accessible to many more people, and the proportion of first-time horse owners 
presumably increased.  First-generation horse owners cannot benefit from the ‘instinct’ and 
knowledge of experienced relatives.  Despite the plethora of literature available on horse care, 
a novice owner will make different judgement calls about husbandry and when to call for 
veterinary attention, when compared with a more experienced horse-person.  It is possible that 
both  an  increase  in  available  information,  and  a lack  of horse care  experience, may  have 
contributed to the apparent changes in disease prevalence seen in this study.   C. E. Walls    0910764w 
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Not surprisingly, musculoskeletal disease remained the most frequently observed category of 
disease in horses.  Its dominance probably stems from a combination of the fragile, unique 
anatomy of the equine locomotor system, and the intensity and diversity of work to which 
these animals are put.   
 
In the thirty years that elapsed between the BEVA and HRH studies significant advances were 
made in veterinary research across many fields.  The precise nutritional requirements of horses 
of  every  size  and  activity  level  were  deduced  and  a  plethora  of  scientifically  formulated 
feedstuffs  became  available.    As  Harris  opined  in  1999,  it is probable  that  ‘almost every 
permutation of feeding regimen could be found somewhere in the UK’ (Harris 1999).  Diet 
could affect the prevalence of alimentary disease directly by being a cause of colic or gastric 
ulceration,  for  example  (Harris  1998;  Durham  2009).    Feeding  practices  have  also  been 
identified as important in the genesis of disease (Harris 1999; Luthersson et al. 2009).  The 
relative reduction in cases of alimentary disease in the HRH study may in part reflect the 
evolution of improved, scientifically derived feeds and feeding regimens.   
 
Novel anthelmintic agents to supersede phenothiazine were discovered after the 1960s, such as 
the benzimidazoles and the organophosphates (Lyons et al. 1999). Discovery of the efficacy of 
levamisole,  pyrantel  and  the  macrocyclic  lactones  in  the  1970s  and  1980s  improved  the 
control  of  helminths  in  the  UK  dramatically,  and  intensive  research  into  mechanisms  of 
parasite  resistance  allowed  worming  strategies  and  pasture  management  techniques  to  be 
found which could reliably reduce worm burdens (Lyons et al. 1999).  Although Mellor et al. 
reported that owners surveyed in the HRH study were worming their horses at suboptimal 
frequencies, due to the use of more efficacious products and improved worming regimens it is 
likely that worm control in the 1990s was greatly superior to the 1960s (Mellor et al. 2001).  
The apparent reduction in reporting of alimentary disease may also be linked to the increasing 
tendency of horse owners to utilise the services of Equine Dental Technicians in the event of 
supposed alimentary disease, rather than the veterinarian. 
 
Vaccination against infectious agents such as Influenza A are now widespread.  Influenza 
vaccines were first produced in the 1960s as inactivated whole virus or viral surface antigens 
(Minke et al. 2004).  The protection offered by these early vaccines correlated well with the C. E. Walls    0910764w 
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amount  of  circulating  antibody  to  the  haemagglutinin  surface  glycoprotein,  but  the  large 
outbreak  of  influenza  in  1979  proved  that  the  protection  offered  by  these  vaccines  was 
suboptimal (Minke et al. 2004).  Current vaccines have been manufactured which offer greater 
efficacy, with new adjuvants for improved potency.    Hotchkiss et al. reported in 2007 that 
nearly 56% of horses in Great Britain were vaccinated against influenza and tetanus, with only 
9.2%  of  horses  never  being  vaccinated  (Hotchkiss  et  al.  2007).    Mellor  et  al.  reported  a 
population mean rate of vaccination of 0.8 ± 0.41 doses/horse/year of horses in Scotland and 
northern England in the HRH study, and that 17% of horses were never vaccinated (Mellor et 
al. 2001).  This rate falls below the recommended vaccination rate of 1 dose/horse/year (for 
influenza vaccines).  The vaccine coverage of horses in the 1960s is not known, but it is 
thought that the rate of dosing and use of products of improved efficacy in the HRH study 
would likely constitute superior protection from influenza.  The respiratory disease category, 
containing influenza as a possible diagnosis, reduced in its contribution to disease diagnoses 
between the BEVA and HRH studies.  It is possible that this reduction could be linked to 
improved protection from influenza by vaccination.   
 
In conclusion, these studies have provided the most comprehensive description of the equine 
population of Great Britain in terms of its composition and disease experience.  Given the size 
of  the  equine  population  and  its  connectedness  with  human,  domestic  and  wild  animal 
populations, the importance of up to date and accurate information on the health status of such 
a significant biomass cannot be overstated. 
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CHAPTER 3 - Preliminary Findings of a Case-Control Study of 
Zoonotic Enteric Diseases in Rural Western Kenya 
 
Abstract 
Diarrhoea is the second most common  cause of death of children under 5 
years of age in the developing world, and accounts for more child deaths than 
measles,  malaria  and  HIV  combined.   An  important cause of  such  enteric 
disturbances is infection with pathogenic organisms, many of which may be 
acquired  through  zoonotic  transmission  from  domestic  animal  species.  
Detailed  epidemiological  information  regarding  the  causative  agents 
implicated in diarrhoeic disease in western Kenya is lacking.  The Kenyan 
Medical  Research  Institute  (KEMRI)  in  collaboration  with  the  Centres  for 
Disease Control and Prevention (CDC) began conducting a case-control study 
of diarrhoeic children in western Kenya in 2008.   
Results 
Ninety  seven  and  a  half  percent  of  compounds  housed  chickens,  75.9% 
housed dogs and 74.7% kept cattle, other species were less common.  Two 
point  four  percent  of  pooled  animal  faecal  samples  were  classified  as 
diarrhoeic faeces, 66.7% of which were from young animals.  The following 
pathogens were found in animal faecal samples at the stated prevalences (all 
animal species sample results combined); E. coli 99.3%, Salmonella enterica 
6.6%,  Campylobacter  jejuni  1.8%,  Campylobacter  coli  0.7%,  Salmonella 
typhi 0.2%, Giardia spp. 10.2% and Cryptosporidium spp. 2.5%.  In stool 
samples from children, the following pathogens were found to be marginally 
more prevalent in cases versus than controls; C. jejuni, C. coli, S. enterica, 
and  Cryptosporidium.    Giardia  spp.  were  more  prevalent  among  control 
children  than  cases.    No  statistically  significant  associations  were  found 
between  the  presence  of  any  of  the  identified  pathogens  in  the  animal 
population of a compound with its presence in the child samples of the same 
compound. 
 
 
 C. E. Walls    0910764w 
45 
 
 
3.1 Introduction 
 
Diseases of animal origin are prevalent throughout the world.  Enteric disturbances such as 
diarrhoea are a very common manifestation of such diseases.  The Centres for Disease Control 
and Prevention (CDC) estimate that 75% of recently emerging infectious diseases of humans 
originated from animal sources some time in the past(www.cdc.gov 2010).  Developing parts 
of the world often suffer high rates of such infections due in part to a lack of safe drinking 
water, poor hygiene and poor sanitation, coupled with living in close proximity to domestic 
animal species.  Young children are particularly susceptible to dehydration from diarrhoea due 
to  their  relatively  high  metabolic  rate:  therefore  diarrhoea  is  a  leading  cause  of  death  in 
children under 5 years of age, worldwide (www.who.int 2010).  In Kenya it is estimated that 
16% of the deaths of children under the age of five years are due to diarrhoea, but the precise 
combination of enteric pathogens implicated is unknown (www.who.int 2010).  In 2008 a 
large scale case-control study by the CDC, in collaboration with the Kenyan Medical Research 
Institute (KEMRI), began in order to identify those pathogens present in stool samples from 
diarrhoeic young children in western Kenya, and the lifestyle factors associated with infection.  
In order to study the contribution of zoonotic enteric pathogens to this disease profile, the 
Zoonotic  Enteric  Diseases  Study  (ZED)  was  designed  to  run  alongside  the  child  study 
(GEMS).  Sample collection and analysis are ongoing at the time of writing.  The aims of the 
ZED study are to identify which potentially zoonotic pathogens are implicated in the burden of 
childhood  diarrhoea  within  the  test  area,  and  to  generate  recommendations  for  practical 
interventions which could reduce the rate of infection in the future.  This paper reports on 
some of the preliminary results from the testing of both animal and child faecal samples.  For 
the purposes of this study, the term ‘zoonotic’ is taken to mean those infectious diseases, 
harboured by animals, which are considered to be a threat to humans in the present day, as 
opposed to those pathogens which became infectious to humans in the past but are no longer 
acquired from animal sources. 
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3.2 Materials and Methods 
 
3.2.1 Global Enterics Multi-Centre Study (GEMS) 
 
The Global Enterics Multi-Centre Study (GEMS) called ‘Diarrhoeic Disease in Infants and 
Young Children in Developing Countries’ commenced in 2008.  Children under five years of 
age suffering from moderate to severe diarrhoea, who received medical attention in the Gem 
and Asembo Demographic Surveillance System Area of rural western Kenya were invited to 
become enrolled as ‘cases’ in the GEMS study.  The guardian of each case child completed a 
questionnaire  covering  subjects  such  as  the  child’s  age  and  sex,  hygiene  practices,  water 
sources, water storage and handling, and whether domestic animals were kept in or near the 
home.    A  faecal  sample  was  taken  from  each  child  to  be  processed  at  the  KEMRI/CDC 
laboratories at Kisian.  Another, non-diarrhoeic, child from the same compound which was 
matched  for  age  and  sex  with  the  case  child,  was  enrolled  as  a  control.    The  same 
questionnaire  and  faecal  sample  processes  were  used  with  case  and  control  children.  
Enrolment and sample testing procedures are ongoing at the time of writing. 
 
3.2.2 Zoonotic Enteric Diseases Study (ZED) 
 
The caretakers of case and control children in the GEMS study which reported the presence of 
domestic animals on their compound were approached to be enrolled on the ZED study.  Each 
enrolled compound was visited within 3 days of a child being included into GEMS, and two 
questionnaires were administered.  The first questionnaire was administered to the caretaker of 
the child in question, and covered current and recent animal ownership, management, handling 
practices,  and  risk  factors  for  exposure  to  animals  and  their  environment.    The  second 
questionnaire  was  administered  to  the  head  of  each  compound,  in  order  to  ascertain  the 
numbers,  age  groups  and  species  of  domestic  animals  housed  on  the  compound.    Faecal 
samples were collected from all or a proportion of the domestic animals present, depending on 
population size.  For large animals, faecal samples were collected per rectum using a gloved 
hand or digit.   For small animals such as puppies and kittens, sampling was achieved by 
inserting a sterile cotton swab into the rectum.  Poultry were confined on a thick plastic sheet 
overnight and the droppings collected the following morning.  All faecal samples were pooled 
by animal species and age group (‘young’ i.e. unweaned, ‘adult’ i.e. weaned, or ‘mixed ages’), C. E. Walls    0910764w 
47 
 
with a maximum of 5 animal samples per pool, and a maximum of 2 pools per species/age 
group, with each pool being thoroughly mixed using a sterile spatula.  Three rectal or cloacal 
swabs were also collected per animal, two of which were placed into Cary Blair medium, and 
one into buffered glycerol saline (BGS).  All samples were appropriately labelled and stored 
on  ice  for  transport  to  the  laboratory.    The  processes  involved  in  the  ZED  study  are 
summarised below (see Figure 3.1). 
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Figure 3.1 Flowchart for the Zoonotic Enteric Diseases Study. 
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3.2.3 Sample Testing 
 
Faecal  samples  from  the  case  and  control  children  were  subjected  to  various  laboratory 
procedures  to  identify  a  range  of  enteric  pathogens  including  Salmonellae,  Shigella  spp., 
Cryptosporidium  spp.,  Giardia  spp.,  Norovirus,  E.  coli  and  Campylobacter.    Procedures 
implemented included Reverse-Transcriptase Polymerase Chain Reaction (RT-PCR), bacterial 
culture on selective media, and Enzyme-Linked Immunoassays (ELISAs).  Typing and sub-
species  determination  of  pathogens  recovered  was  completed  at  KEMRI  laboratories  if 
appropriate equipment and skills were available: alternatively samples were shipped to the 
CDC in Atlanta, US.  Animal faecal samples were also cultured to identify bacterial species 
using the same methods as the GEMS study, and were subjected to ELISA using commercial 
immunoassay  kits  to  detect  Giardia  spp.  or  Cryptosporidium  spp.  (Wampole  Giardia  II, 
TechLabs, Wampole Cryptosporidium II, TechLabs).  Testing for the detection and sub-typing 
of the following pathogens is ongoing; E. coli, Salmonella, Shigella spp., Campylobacter, 
Giardia spp., Cryptosporidium spp., Rotavirus.  Figure 3.2 illustrates a simplified version of 
the processes for pathogen detection used in the ZED study.  
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Figure 3.2 Simplified flow chart depicting the stages of faecal sample processing to identify 
zoonotic enteric pathogens in the ZED study.  Detailed biochemical testing procedures, sub-
typing and further speciation methods are beyond the scope of this paper. 
 
Data  collected  in  the  ZED  study  were  computerised  using  optically  scannable  forms  and 
Teleform  software,  and  stored  in  a  Microsoft  Access  Database,  which  was  subsequently 
exported into Microsoft Excel for analysis.  Where possible, associations between variables 
were investigated using Fisher’s Exact Tests. 
 
3.3 Results 
 
3.3.1 Animal Faecal Samples 
 
In  total  511  pooled  animal  faecal  samples  were  collected  and  stored  at  KEMRI  (Kisian, 
western  Kenya)  between  the  27th  November  2009  and  1
st  February  2010.    To  date,  455 
samples have been subjected to bacterial culture, and 403 to enzyme-linked immunoassay 
(ELISA) for protozoa (Giardia spp. and Cryptosporidium spp.).  Between 1 and 9 animals 
contributed to each pool (mean 3.1, median 5).  The species and age distribution of all pools 
collected is shown in Table 3.1.   C. E. Walls    0910764w 
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Table 3.1 Age classification and species of all faecal sample pools in GEMS-ZED database, 
n=511. 
 
Number (%) of animal faecal sample pools of each age group and 
species 
  Young  Adult  Mixed  Total 
Cattle  77 (20.5)  30 (29.4)  1 (3.0)  108 (21.1) 
Sheep  34 (9.0)  9 (8.8)  1 (3.0)  44 (8.6) 
Goats  68 (18.1)  19 (18.6)  1 (3.0)  88 (17.2) 
Chickens  98 (26.1)  39 (38.2)  27 (81.8)  164 (32.1) 
Dogs  57 (15.2)  0 (0.0)  0 (0.0)  57 (11.2) 
Cats  32 (8.5)  3 (2.9)  0 (0.0)  35 (6.8) 
Donkeys  9 (2.4)  2 (2.0)  0 (0.0)  11 (2.2) 
Ducks  1 (0.3)  0 (0.0)  3 (9.1)  4 (0.8) 
All Animals  376 (100.0)  102 (100.0)  33 (100.0)  511 (100.0) 
 
Twelve  (2.4%)  pools  were  classified  as  diarrhoeic,  2  (0.4%)  contained  blood,  1  (0.2%) 
contained pus and 3 (0.6%) contained mucus (see Table 3.2).  Of those pools which were 
diarrhoeic, 8 (66.7%) were classified as young (unweaned), 2 (16.7%) as adult (weaned), and 
2 (16.7%) contained samples from animals of mixed ages.  
 
Table 3.2 Number (% within each species) of faecal specimen pools which were classified as 
diarrhoeic, non-diarrhoeic, or containing pus, mucus or blood. 
 
Total 
Pools 
Not 
diarrhoea 
Diarrhoea 
Blood 
Present 
Pus 
Present 
Mucus 
Present 
Cattle  108  103 (95.4)  5 (4.6)  1 (0.9)  0 (0.0)  0 (0.0) 
Goat  86  80 (93.0)  6 (7.0)  1 (1.2)  0 (0.0)  3 (3.5) 
Sheep  43  43 (100.0)  0 (0.0)  0 (0.0)  1 (2.3)  0 (0.0) 
Chicken  164  163 (99.4)  1 (0.6)  0 (0.0)  0 (0.0)  0 (0.0) 
Dog  57  57 (100.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
Cat  35  35 (100.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
Donkey  11  11 (100.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
Duck  4  4 (100.0)  0 (0.0)  0 (0.0)  0 (0.0)  0 (0.0) 
 
 
E. coli was the pathogen most frequently detected in animal faeces, with an overall prevalence 
of 99.3% (see Table 3.3).  Other bacterial pathogens were found to have a low prevalence C. E. Walls    0910764w 
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across all species sampled, with the exception of Salmonella enterica in chickens (13.2%) and 
cats (11.8%).  Of those protozoal genera identified using commercial ELISA kits, Giardia spp. 
were most prevalent, with ovine and canine species having a Giardia prevalence of 25.7% and 
32.0%, respectively. 
 
Table 3.3 Results of animal faecal sample tests by either bacterial culture, or ELISA. 
 
Positive test results/Total tests run 
(%) 
  Sheep  Cattle  Goats  Chickens  Dogs  Cats  Donkeys  Ducks 
All 
Species 
C. jejuni 
0/37 
(0.0) 
0/99 
(0.0) 
0/70 
(0.0) 
8/152 
(5.3) 
0/50 
(0.0) 
0/34 
(0.0) 
0/10 
(0.0) 
0/3 
(0.0) 
8/455 
(1.8) 
C. coli 
0/37 
(0.0) 
0/99 
(0.0) 
2/70 
(2.9) 
1/152 
(0.7) 
0/50 
(0.0) 
0/34 
(0.0) 
0/10 
(0.0) 
0/3 
(0.0) 
3/455 
(0.7) 
S. typhi 
0/37 
(0.0) 
0/99 
(0.0) 
0/70 
(0.0) 
1/152 
(0.7) 
0/50 
(0.0) 
0/34 
(0.0) 
0/10 
(0.0) 
0/3 
(0.0) 
1/455 
(0.2) 
S. enterica 
1/37 
(2.7) 
0/99 
(0.0) 
1/70 
(1.4) 
20/152 
(13.2) 
4/50 
(8.0) 
4/34 
(11.8) 
0/10 
(0.0) 
0/3 
(0.0) 
30/455 
(6.6) 
E. coli 
37/37 
(100.0) 
96/99 
(97.0) 
70/70 
(100.0) 
152/152 
(100.0) 
50/50 
(100.0) 
34/34 
(100.0) 
10/10 
(100.0) 
3/3 
(100) 
452/455 
(99.3) 
Giardia 
spp. 
9/35 
(25.7) 
6/95 
(6.3) 
5/67 
(7.5) 
5/143 
(3.5) 
16/50 
(32.0) 
0/34 
(0.0) 
0/10 
(0.0) 
0/3 
(0.0) 
41/403 
(10.2) 
Cryptosp-
oridium 
spp. 
0/35 
(0.0) 
0/95 
(0.0) 
0/67 
(0.0) 
7/143 
(4.9) 
3/50 
(6.0) 
0/34 
(0.0) 
0/10 
(0.0) 
0/3 
(0.0) 
10/403 
(2.5) 
 
 
3.3.2 Child Stool Sample Results 
 
In total to date, 127 children have been enrolled onto the GEMS study, of which 50 are cases 
and 77 are controls.  Of those children, 79 have also been enrolled onto the ZED study, of 
which 39 are cases and 40 controls.  The average age of case children is 16.2 months (range 2-
48 months), and 53.8% (21/39) are male.  The average age of control children is 16.4 months 
(range 0-48 months) and 52.5% (21/40) are male.  The animals present at compounds where 
case or control children reside is given in table 3.4 below. C. E. Walls    0910764w 
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Table 3.4 Reported number (%) of compounds to house each animal species. 
Animal species present at residential compounds 
 
Cattle 
(%) 
Sheep 
(%) 
Goats 
(%) 
Dogs 
(%) 
Cats 
(%) 
Fowl 
(%) 
Donkeys 
(%) 
No 
animals 
(%) 
Cases  
n=39 
30 (76.9)  15 (38.5) 
29 
(74.4) 
27 
(69.2) 
23 
(59.0) 
37 
(94.9) 
3 (7.7)  1 (2.6) 
Controls  
n=40 
29 (72.5)  16 (40.0) 
24 
(60.0) 
33 
(82.5) 
33 
(82.5) 
40 
(100.0) 
1 (2.5)  0 (0.0) 
Total 
n=79 
59 (74.7)  31 (39.2) 
53 
(67.1) 
60 
(75.9) 
56 
(70.9) 
77 
(97.5) 
4 (5.1)  1 (1.3) 
 
E. coli was the most frequently isolated bacterial species in the child samples (see Table 3.5).  
The prevalence of C. jejuni, C. coli, S. typhi and E. coli were similar or slightly higher in case 
versus  control  children.    S.  enterica  was  more  prevalent  among  cases  than  controls,  and 
Giardia spp. were found to be more prevalent among controls than cases.  
 
Table 3.5 Prevalence of select pathogens found in child faecal samples. 
Number (%) of faecal samples positive per  pathogen 
 
C. jejuni 
(%) 
C. coli 
 (%) 
S. typhi 
(%) 
S. enterica 
(%) 
E. coli 
(%) 
Giardia 
spp. (%) 
Cryptosporidium 
spp. (%) 
Cases  
n=39 
5 (12.8)  1 (2.6)  0 (0.0)  4 (10.3) 
38 
(97.4) 
7 (18.0)  6 (15.4) 
Controls  
n=40 
4 (10.0)  0 (0.0)  0 (0.0)  0 (0.0) 
39 
(97.5) 
12 (30.0)  2 (5.0) 
Total 
n=79 
9 (11.4)  1 (1.3)  0 (0.0)  4 (5.1) 
77 
(97.5) 
19 (24.1)  8 (10.1) 
 
Table  3.6  shows  that  the  majority  of  samples  were  negative  for  bacterial  and  protozoal 
enteropathogens (excluding E. coli) in both the child and animal samples tested.  E. coli was 
equally highly prevalent among the child and animal samples of cases and controls.   
 
 
 
 
Table 3.6 Compound allocation into pathogen present (+), absent (-) or missing (m) in 
sampled children, and animals. (Crypto. spp. = Cryptosporidium species). C. E. Walls    0910764w 
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      Animal Sample Results 
      C. jejuni  C. coli  S. typhi  S. enterica  E. coli 
Giardia 
spp. 
Crypto. 
spp. 
      -  +  m  -  +  m  -  +  m  -  +  m  -  +  m  -  +  m  -  +  m 
C
h
i
l
d
 
S
a
m
p
l
e
s
 
C
a
s
e
s
 
 
n
=
3
9
 
-  31  2  0  37  0  0  38  0  0  28  6  0  0  0  0  17  11  0  27  2  0 
+  4  1  0  1  0  0  0  0  0  4  0  0  1  37  0  4  3  0  6  0  0 
m  1  0  0  1  0  0  1  0  0  1  0  0  0  1  0  4  0  0  4  0  0 
C
o
n
t
r
o
l
s
 
n
=
4
0
 
-  33  2  0  39  0  0  38  1  0  27  12  0  0  0  0  17  7  0  33  1  0 
+  4  0  0  0  0  0  0  0  0  0  0  0  1  38  0  7  5  0  2  0  0 
m  0  1  0  1  0  0  1  0  0  0  1  0  0  1  0  3  1  0  2  2  0 
 
A
l
l
 
S
a
m
p
l
e
s
 
n
=
7
9
 
-  64  4  0  76  0  0  76  1  0  55  18  0  0  0  0  34  18  0  60  3  0 
  +  8  1  0  1  0  0  0  0  0  4  0  0  2  75  0  11  8  0  8  0  0 
  m  1  1  0  2  0  0  2  0  0  1  1  0  0  2  0  7  1  0  6  2  0 
 
The  detected  presence  of  any  of  the  above  pathogens  within  the  animal  population  of  a 
compound was found not to be statistically significantly associated with the presence of that 
pathogen in the child stool sample of the same compound (p>0.05).  Age group and pool size 
were not found to be predictors of detection of any of the above pathogens.  A pool size of 2 
(i.e. 2 animal samples contributing to one pool) was found to be most likely to test positive for 
at least one enteropathogen, in comparison to other pool sizes (see Table 3.7).  Twenty percent 
of pools were found to contain at least one of the target pathogens (excluding E. coli).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   C. E. Walls    0910764w 
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Table 3.7 The number of animal faecal samples contributing to a pool (‘pool size’), versus the 
number (and proportion) of those pools found to contain at least one of the following 
pathogens; Campylobacter jejuni, Campylobacter coli, Salmonella typhi, Salmonella enterica, 
Giardia or Cryptosporidium.  
 
Pool Size 
Number (%) of pools with at 
least one positive pathogen 
result (excluding E. coli) 
Total number of pools 
subjected to both culture and 
ELISA 
1  15 (19.0)  79 
2  21 (28.0)  75 
3  10 (20.4)  49 
4  6 (12.5)  48 
5  28 (19.0)  143 
Over 5  1 (25.0)  4 
All Pool Sizes  81 (20.4)  398 
 
Animal and child sample results which were available for analysis were grouped according to 
the calendar year in which the sample was received at the laboratory.  Six full months of 
results for GEMS (November to April) and seven full months of ZED results (December to 
June) were available for analysis (see Figures 3.3 and 3.4).  Preliminary test results for six 
selected pathogens revealed that most positive test results were recorded for those samples 
received in February in both animal and child faecal samples. 
 
   C. E. Walls 
 
 
 
Figure 3.3 Temporal ‘pattern’ of positive test results (by bacterial culture or ELISA) in child 
stool samples by month of enrolment onto GEMS.
 
Figure 3.4 Temporal ‘pattern’ of positive test results (by bacterial culture or ELISA) in animal 
faecal samples by month of enrolment onto GEMS
 
3.4 Discussion 
 
The importance of the contribution of zoonotic enteric pathogens to the disease burden of 
children in the developing world should not be underestimated.  The WHO estimates that 2.5 
billion cases of childhood diarrhoea occur annually, resulting in 1.5 milli
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which a large proportion are due to avoidable enteric infections .  Diarrhoea is responsible for 
16% of the deaths of children under 5 years old in Kenya, the second most common cause of 
death after pneumonia (www.who.int 2010).  From initial survey results from the GEMS study 
it was found that in the rural area being sampled, 99% of caretakers of young children reported 
the presence of domestic animals in or near the home.  This figure excluded dogs, thus the true 
prevalence of animal ownership on residential compounds is likely to approach 100%.  There 
is  much  evidence  to  support  the  role  of  zoonotic  pathogens  in  human  disease,  but  the 
prevalence of those pathogens likely to be implicated in rural western Kenya is yet to be fully 
elucidated (Atabay and Corry 1998; Nataro and Kaper 1998; Adak et al. 2002; Caccio et al. 
2005; Hunter and Thompson 2005; Thompson et al. 2005; Gatei et al. 2006; Stirling et al. 
2008).  Exposure of children to zoonotic pathogenic organisms could occur through close 
contact, handling, sharing of environments, and the consumption of undercooked eggs, other 
foods of animal origin or of unpasteurised milk, or any other food contaminated with animal 
faeces  (Atabay  and  Corry  1998;  Poppe  et  al.  1998;  Graham  et  al.  2000;  Palombo  2002; 
Sanchez et al. 2002; Kariuki et al. 2006; Stirling et al. 2008; Bank-Wolf et al. 2010).  The 
likelihood of mortality resulting from diarrhoea is increased by failure to instigate effective 
hygiene and sanitation practices, a lack of safe water sources, and failure to provide effective 
medical care.  Up to 61% of childhood diarrhoea cases in the developing world do not receive 
adequate treatment in the form of oral rehydration therapy, which in many cases could prove 
life-saving (www.who.int 2010).  
 
The prevalence of enteropathogens in the domestic animal populations of rural western Kenya 
has not previously been investigated using the methods employed in the GEMS-ZED study.  
Prevalence  of  the  enteropathogens  of  children  and  domestic  animals  included  in  this 
preliminary report cannot be directly compared to figures obtained from other parts of the 
developing world or to older studies, due to a paucity of data in this field, and due to the small 
sample sizes available for analysis here.  
 
The following pathogens were found to be more prevalent among case than control children; 
Campylobacter jejuni, Campylobacter coli, Salmonella enterica, and Cryptosporidium spp.  
However, the difference in prevalence of these pathogens between case and control children 
was not found to be significant.  Of these pathogens, the domestic animal species which was 
found to harbour the target pathogen with the greatest frequency was as follows: C. jejuni - C. E. Walls    0910764w 
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chickens, C. coli - goats, S. enterica - chickens, and Cryptosporidium spp. - dogs.  Although 
each of these pathogens was found at a higher prevalence in case than control children, it is 
not possible to ascribe a causal link between diarrhoea and pathogen presence at this stage, or 
say with any certainty that children were infected through contact with those animal species 
commonly harbouring the pathogen. Chickens were found to be abundant in the compounds 
studied:  indeed  97.5%  of  all  compounds  reported  the  presence  of  chickens,  a  greater 
proportion than reported the presence of any other animal species.  Chickens have been found 
to harbour potentially zoonotic pathogens in a number of previous studies, and this study has 
shown that chickens are carriers of many of the pathogens detected thus far (Atabay and Corry 
1998; Graham et al. 2000; Sanchez et al. 2002).  Due to their abundance in the domestic 
setting and their tendency to harbour certain enteropathogens at a high prevalence, chickens 
may be found to be a significant risk factor for childhood diarrhoea.  
 
Twelve animal faecal sample pools contained diarrhoeic faeces (2.4%).  Animals were not 
excluded from the sampling procedure if they were found to have diarrhoea, nor were they 
specifically sought out, but samples from diarrhoeic animals were pooled separately from non-
diarrhoeic samples.  This number is too small to allow significant associations to be found 
between the presence of animal diarrhoea and the recovery of any particular enteropathogen.  
However, other studies have failed to find any association between animal diarrhoea and the 
presence  of  a  known  enteropathogen  (De  Rycke  et  al.  1986).    The  majority  (66.7%)  of 
diarrhoeic  animal  samples  came  from  young  animals.    Potentially  animals  suffering  from 
diarrhoea  are  more  likely  to  transmit  infectious  zoonotic  enteropathogens  to  susceptible 
children, although this hypothesis could not be tested using the small sample sizes in this 
analysis.  If this is the case, it seems likely that a greater risk to children is posed by the 
presence of young animals than adult animals, as they more commonly suffer diarrhoea, which 
may be of an infectious nature.   
 
Giardia spp. was found to be more prevalent among control children than case children in 
these  preliminary  data.    This  finding  was  found  again  after  analysis  of  the  GEMS-ZED 
database at a later date than was possible for the production of this paper (Omore et al. 2010).  
A significantly higher prevalence among control children may suggest that Giardia spp. are 
acting as a protective factor against childhood diarrhoea through unknown mechanisms.  To 
the authors knowledge this finding has not been previously reported.  The presence of dogs on C. E. Walls    0910764w 
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the compound is reported more commonly by caretakers of control children than case children, 
and dogs were found in this study to harbour Giardia spp. with a higher prevalence than any 
other animal species (32.0%).  The possible link between domestic dog presence, Giardia 
spp., and an absence of diarrhoea in children warrants further investigation. 
 
A temporal (annual or biannual) pattern of detection of some enteropathogens or of childhood 
bacteraemia has been previously reported, often coinciding with the rainy seasons of tropical 
and sub-tropical regions (Graham et al. 2000; Brent et al. 2006; Kariuki et al. 2006; Gordon et 
al. 2008).  A peak of pathogen detection was seen in the animal and child samples submitted 
around February in this study.  In Kenya, the long rainy season occurs from March to May, 
thus February could be thought of as a ‘dry’ month.  High pathogen prevalence in child and 
animal faecal samples at this time could relate to a restricted water supply owing to the lack of 
rain, which leads available water sources to be overused and more likely contaminated.  This 
explanation differs from those offered for peaks of pathogen detection during rainy seasons, 
which often relate to contamination due to flooding (Brent et al. 2006; Kariuki et al. 2006; 
Gordon et al. 2008).  Small numbers of test results were available for analysis for the purposes 
of  this  report,  and  less  than  one  year  of  sample  submissions  could  be  analysed,  thus 
determination of any temporal pattern in positive results is tentative but will be studied in 
detail at the conclusion of the GEMS-ZED study. 
 
To determine that the route of infection for a diarrhoeic child was zoonotic, the pathogen(s) 
implicated must be characterised using sub-typing to a certain level effectively to exclude its 
possible  acquisition  from  alternative  sources,  i.e.  the  same  species/sub-type/serotype  of 
pathogen must be recovered from both the child and the animal in question (Nataro and Kaper 
1998; Adesiyun et al. 2001; De Grazia S. et al. 2007; Smith et al. 2007; Koopmans 2008; Xiao 
and Fayer 2008; Bank-Wolf et al. 2010).  Even when this information is known, it is not 
possible to be certain that zoonotic transmission occurred, as the direction of transfer may 
have been anthroponotic, for example.  However, in these circumstances, zoonotic transfer is 
usually inferred.  To allow identification of those pathogens and the animal species involved 
in possible zoonotic transfer to children, the GEMS-ZED study aims to characterise all of the 
pathogens involved using various methods.  Pathogens other than those discussed in this paper 
are also being investigated for their role in childhood diarrhoea, e.g. Rotavirus, Norovirus, 
Shigella spp.  This testing was not complete at the time of writing. C. E. Walls    0910764w 
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Some of the pathogens featured in the GEMS-ZED study are not shed from their host in a 
constant,  predictable  manner.    For  example  Giardia  spp.  are  often  shed  in  a  cyclically, 
therefore multiple pooled faecal samples are required for reliable diagnosis by faecal cyst 
detection methods.  Although animal faecal samples in the GEMS-ZED study were pooled to 
include up to 9 animal samples per pool, some pools contained very few samples, therefore 
false negative results may have occurred.   
 
Children in rural western Kenya often live in close proximity with domestic animals, thus are 
likely to be exposed repeatedly to pathogenic organisms harboured by those species.  This 
exposure may confer a degree of immunity to the child, and thus enteric disease as a result of 
infection with those pathogens may become less likely.  Additionally, testing of animal and 
child faecal samples may not detect recent infections, as there will be a delay infection and 
shedding.  This may alter the supposed prevalence of such pathogens to a degree. For these 
reasons, detection of zoonotic enteric pathogens in animal species and children in the GEMS-
ZED study will need to be interpreted with care.   
 
Although zoonotic transfer is often inferred when a specific type of pathogen is detected in 
animal and human samples, it may be the case that person to person transfer occurred, with 
subsequent anthroponotic transfer.  Indeed, person to person transfer could have led to a large 
proportion of the child infections seen thus far in the GEMS-ZED data, which would make 
study of the animal population less important.  However, this theory cannot be proven at the 
present time, but must be taken into account in the final analysis of this data. 
 
The  GEMS-ZED  study  aims  to  identify  those  enteropathogens  implicated  in  childhood 
diarrhoea, the domestic animal species from which they may derive, and to generate advice on 
practical interventions to avoid further infections.  This preliminary report suffers from a lack 
of statistical power due to small sample sizes, and thus there is limited capacity to identify 
significant  associations.    However,  it  does  suggest  that  interesting  trends  in  the  temporal 
pattern of diagnosis, in the possible protective effect of Giardia spp. infection, or domestic 
carnivore presence, may be emerging from these data, and are worthy of further study.    C. E. Walls    0910764w 
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General Conclusions 
 
Project 1 
This  study  proved  that  the  compound  K11777,  an  inhibitor  of  cathepsin  L-like  cysteine 
proteases, has the ability to alter the incidence of spontaneous Ca
2+ ‘waves’ in isolated adult 
rat cardiomyocytes which have previously been subjected to T. b. brucei supernatant.  This 
result suggests that the increase in wave production seen due to the presence of T. b. brucei 
parasites  or  their  supernatant,  is  due  to  parasitic  secretion/excretion  of  a  cathepsin  L-like 
cysteine protease.  It was not possible to prove the involvement of PAR 2 through the use of 
SLIGRL-NH2 in this project. 
 
Accurately pinpointing the pathways and chemical signals involved in the cardiac pathologies 
of Trypanosomiasis may have important implications.  It is possible that there is overlap in the 
mechanisms  by  which  the  parasite  causes  Ca
2+  ‘waves’  (and  therefore  arrhythmias),  and 
penetrates the blood-brain barrier leading to neurological derangement.  If this is the case, a 
drug which is able to abrogate the first effect thereby abolishing cardiac disturbances, may 
also prevent the second effect, thus the major cause of the morbidity and mortality in Human 
African Trypanosomiasis could potentially be prevented.  Future research should focus on 
establishing  which  PAR(s)  (if  any)  are  involved  in  the  instigation  of  intracellular  Ca
2+ 
‘waves’,  through  more  extensive  use  of  both  PAR-APs  and  inhibitory  molecules.    The 
hypothesis of protease activation of the iRAS pathway should also be investigated in further 
studies. 
 
Project 2 
As  was hypothesised,  the  profile  of  equine  disease  in  the UK (as  defined  by  the  relative 
proportions of disease categories reported to veterinarians) was found to have significantly 
altered in the time between the BEVA and HRH studies in this project.  There was also some 
evidence that the composition of the equine population of northern UK altered over the test 
period, in terms of the types of breeds present. 
 
The non-racing equine population of the UK is largely neglected in terms of epidemiological 
and  demographic  research,  despite  its  considerable  size  and  the  financial  contributions  it 
provides  to  the  UK  economy.    This  was  certainly  the  case  during  and  before  the  1960s, C. E. Walls    0910764w 
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therefore the BEVA paper used in this comparison stood alone as the only resource available 
with which to define the equine population at that time.  Currently, there are legal safeguards 
of animal welfare which did not exist previously (Animal Welfare Act 2006).  Additionally, 
ongoing data gathering operations (e.g. NED, AHT Quarterly Disease Reports) now aim to 
improve and sustain  knowledge of the equine  population and its infectious disease status.  
However, these resources collect no information on the non-infectious disease burden of the 
population, or on the husbandry and training methods used, and thus the true state of equine 
welfare in the UK is still not known.  This study has provided some direction for further 
research to pinpoint those areas of equine disease which may be becoming more prevalent, 
thereby offering priority areas to target for improving the welfare of this population in the 
future. 
 
Project 3 
Cryptosporidium spp., Giardia spp., Salmonellae, Campylobacter and E. coli are examples of 
enteropathogens  able  to  cause  debilitating  disease  in  children,  particularly  where 
immunocompromise may occur as a result of concurrent infections such as HIV.  For the first 
time, the GEMS-ZED study is attempting to use case-control methods to uncover associations 
between  domestic  animal presence  and  childhood  diarrhoea  in rural  western  Kenya.    The 
conclusions drawn from this study, once complete, will be relevant in many parts of sub-
Saharan Africa, and indeed will also be of use in other areas of the developing world.  This 
project furthered this cause by processing a proportion of the animal samples collected, and 
beginning the analysis of the available data. 
 
The projects undertaken have made modest contributions to the existing bank of information 
in each of the three fields featured, thus have contributed to the advancement of human and 
animal health.   
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